Dermatitis  >>  Eucrisa (crisaborole)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

6 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Eucrisa (crisaborole) / Pfizer
CORE 1, NCT02118766 / 2018-000731-27: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Ages 2 Years and Older) With Atopic Dermatitis

Checkmark Mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: Mild-to-moderate atopic dermatitis
Checkmark For mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: For mild-to-moderate atopic dermatitis
Completed
3
763
US
AN2728 Topical Ointment, 2%, Matching vehicle control
Pfizer
Dermatitis, Atopic
04/15
04/15
CORE 2, NCT02118792: Safety and Efficacy of AN2728 Topical Ointment, 2% in Children, Adolescents, and Adults (Aged 2 Years and Older) With Atopic Dermatitis

Checkmark For mild-to-moderate atopic dermatitis
Jul 2015 - Jul 2015: For mild-to-moderate atopic dermatitis
Completed
3
764
US
AN2728 Topical Ointment, 2%, Matching vehicle control
Pfizer
Dermatitis, Atopic
04/15
04/15
NCT04498403 / 2021-001266-38: A Study of the Long-Term Safety of Crisaborole Ointment, 2% in Japanese Pediatric and Adult Participants With Mild to Moderate Atopic Dermatitis

Terminated
3
40
Japan
Crisaborole 2%
Pfizer, Pfizer Inc.
Atopic Dermatitis
12/20
12/20
NCT04360187 / 2021-006538-38: Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis

Completed
3
391
Japan, RoW
Crisaborole Ointment, Crisaborole Placebo Vehicle
Pfizer
Atopic Dermatitis
09/21
09/21
NCT04040192 / 2019-000443-28: A Study to Evaluate Long-Term Maintenance Treatment With Once Daily Crisaborole Ointment 2% in Pediatric and Adult Participants With Mild-to-Moderate Atopic Dermatitis

Completed
3
620
Canada, US, RoW
Crisaborole 2%, Vehicle
Pfizer
Atopic Dermatitis
01/22
01/22
NCT05016284: Comparison of JW-100 and EUCRISA for the Treatment of Atopic Dermatitis

Withdrawn
3
0
RoW
JW-100, Eucrisa
Applied Biology, Inc., Jupiter Wellness, Inc.
Atopic Dermatitis
12/22
12/22

Download Options